Instrument Inactif

Communiqués Icagen, Inc.

Actions

US45104P5008

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

2011	Le point sur les marchés	RE
2011	Wall St termine en nette hausse, rebond des bancaires	RE

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

ICAGEN IN : Ryan & Maniskas, LLP Announces Investigation of Icagen, Inc.	21/07/11	BU
ICAGEN IN : Murray Frank LLP Investigates Icagen, Inc.	21/07/11	BU
ICAGEN IN : The Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of Icagen, Inc.	21/07/11	BU
ICAGEN IN : Law Office of Brodsky & Smith, LLC Announces Investigation of Icagen, Inc.	20/07/11	BU
ICAGEN IN : Law Firm Brower Piven Announces Investigation of Icagen, Inc.	20/07/11	BU
ICAGEN : Xmark Requests That Icagen Oust Its CEO and Pursue Strategic Alternatives, and Calls on Board Members to Resign	01/04/09	PR
ICAGEN : Board Beginning to Follow Xmark Direction	02/02/09	PR
ICAGEN : Xmark Sends Letters to Icagen's Board of Directors: Questions Company's Leadership as Well as Motives Behind Adoption of Poison Pill	20/01/09	PR
ICAGEN : to Report Second Quarter 2008 Results and Conduct Conference Call on August 5, 2008	29/07/08	PR
Icagen : Icagen Scientists to Be Featured at Upcoming Industry Forums	01/10/07	BU
Icagen : Icagen to Present at the UBS Global Life Sciences Conference	17/09/07	BU
Icagen : Icagen Announces Initiation of Phase I Study of ICA-105665, a Novel Compound for the Treatment of Epilepsy	05/09/07	BU
Icagen : Icagen Announces First Closing of Investment by Pfizer	20/08/07	BU
Icagen : Icagen Announces Investment by Pfizer	14/08/07	BU
Icagen : Icagen Announces Alliance with Pfizer in Ion Channel-Focused Therapeutics for Pain and Related Disorders	14/08/07	BU
Icagen : Icagen Reports Second Quarter 2007 Financial Results	03/08/07	BU
Icagen : Icagen Announces Second Quarter Conference Call	25/07/07	BU
Icagen : Icagen Announces Filing of Ind for ICA-105665, a Novel Compound for the Treatment of Epilepsy	24/07/07	BU
Icagen : Icagen to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference	09/07/07	BU
Icagen : Icagen Receives Notification from McNeil of Termination of Collaboration Agreement	21/06/07	BU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Icagen, Inc.

Actions

US45104P5008

Communiqués

Filtres